An oral formulation of gold for the treatment of rheumatoid arthritis
Related Experiment Video
Updated: Oct 12, 2026

Hydroquinone Based Synthesis of Gold Nanorods
Published on: August 10, 2016
Abstract:
Twenty-two patients with active rheumatoid arthritis were entered into a trial during which an oral gold formulation was administered at two dosages (4 mg/d and 6 mg/d) for 12 weeks. Seventeen patients completed the trial. Both dosages produced a similar improvement in the indices of inflammation. Five patients were not benefited by the treatment, adverse side-effects were reported in 10 and 5 were withdrawn from the trial.
Related Concept Videos
Immunogold Electron Microscopy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Oral Drug Delivery Systems: Introduction
Rheumatic Heart Disease III: Medical Management

